Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 787

Results For "IP"

10338 News Found

Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine
Biotech | May 13, 2022

Ultivue announces AI Partner Ecosystem to accelerate research in translational medicine

Image and data analysis of rich spatial information from mIF images can accelerate tissue biomarker discovery and validation


All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week
News | May 13, 2022

All India Institute of Ayurveda (AIIA) celebrates Nurses Awareness Week

As part of the celebrations, the Institute organised a series of activities in the run up to International Nurses Day which is observed on 12th May every year


The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners
interviews | May 12, 2022

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

Candle Partners, an investment banking & advisory service for M&A among others, has closed many deals in the healthcare space. Ankit Poddar, Director, Candle Partners spoke to Thomas C Thottathil, Editor, Indianpharmapost.com about the prospects for the industry.


New two-year Deucravacitinib data show promising results for severe plaque psoriasis
Biotech | May 12, 2022

New two-year Deucravacitinib data show promising results for severe plaque psoriasis

Deucravacitinib is currently under regulatory review in multiple regions, including the U.S., Europe and Japan, and would be the first selective allosteric tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease


Mawi DNA Technologies launches NextSWAB for Covid-19 test results
Biotech | May 12, 2022

Mawi DNA Technologies launches NextSWAB for Covid-19 test results

NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing


Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal
News | May 12, 2022

Boehringer Ingelheim’s signal analytics technology acquired by ArisGlobal

ArisGlobal acquires Boehringer Ingelheim’s Benefit-Risk Analytic System (BRASS), a software solution designed to support causal analysis of drug safety data in a highly regulated environment


GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech
Medical Device | May 12, 2022

GenNext Technologies introduces protein footprinting products to Japan through Kiko Tech

GenNext and Kiko Tech will provide sales and marketing, customer service, technical support, training, and related logistical efforts for Flash Oxidation Protein Footprinting Systems.


OvaCis rapid test to detect ovarian cancer gets CE mark
Drug Approval | May 12, 2022

OvaCis rapid test to detect ovarian cancer gets CE mark

Revolutionary ovarian cancer rapid test available Q4 2022


First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial
Biotech | May 12, 2022

First patient dosed with antiepileptic drug candidate CB03 in a first-in-human Phase I trial

CB03 is a candidate drug for the treatment of refractory epilepsy, independently developed by Zhimeng


USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19
Drug Approval | May 12, 2022

USFDA approves Lilly and Incyte's Olumiant to treat hospitalised patients with Covid-19

Olumiant is the first and only JAK inhibitor USFDA-approved for the treatment of Covid-19